IHC-P analysis of human breast adenocarcinoma tissue using GTX84306 IGF2BP2 antibody [3F9].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of human colon adenocarcinoma tissue using GTX84306 IGF2BP2 antibody [3F9].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

ICC/IF analysis of COS7 cells transiently transfected with IGF2BP2 plasmid using GTX84306 IGF2BP2 antibody [3F9].

WB analysis of various cell lines using GTX84306 IGF2BP2 antibody [3F9].
Loading : 35 ug per lane

FACS analysis of HEK293T cells transfected with either IGF2BP2 plasmid(Red) or empty vector control plasmid(Blue) using GTX84306 IGF2BP2 antibody [3F9].

WB analysis of HEK293T cells transfected with IGF2BP2 plasmid (Right) or empty vector (Left) for 48 hrs using GTX84306 IGF2BP2 antibody [3F9].
Loading : 5 ug per lane

FACS analysis of Jurkat cells using GTX84306 IGF2BP2 antibody [3F9].
Red : Primary antibody
Blue : Negative control antibody

IHC-P analysis of human liver tissue using GTX84306 IGF2BP2 antibody [3F9].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

FACS analysis of HeLa cells using GTX84306 IGF2BP2 antibody [3F9].
Red : Primary antibody
Blue : Negative control antibody

IHC-P analysis of human ovary adenocarcinoma tissue using GTX84306 IGF2BP2 antibody [3F9].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of human kidney tissue using GTX84306 IGF2BP2 antibody [3F9].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50